Stem Bromelain

CHEMBL4298054 Phase 4 Disetujui Enzyme

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

Stem bromelain is a mixture of proteolytic (cysteine protease) enzymes derived from pineapple (Ananas comosus) stem, used clinically as a debridement agent in the NexoBrid product for enzymatic eschar removal in burns, with investigational applications in bladder and breast cancer. The bromelain proteases selectively digest fibrin and denatured proteins in the burn eschar without destroying viable tissue, enabling non-surgical debridement. Its proteolytic activity may also have anti-inflammatory and anticoagulant properties.

Area Terapeutik

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Cardiovascular Disease Non-Small Cell Lung Cancer Generalized Anxiety Disorder Breast Cancer Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Stem bromelain is a mixture of proteolytic (cysteine protease) enzymes derived from pineapple (Ananas comosus) stem, used clinically as a debridement agent in the NexoBrid product for enzymatic eschar removal in burns, with investigational applications in bladder and breast cancer. The bromelain proteases selectively digest fibrin and denatured proteins in the burn eschar without destroying viable tissue, enabling non-surgical debridement. Its proteolytic activity may also have anti-inflammatory and anticoagulant properties.

Yes, Stem Bromelain is an approved drug. It has reached clinical phase 4. It is classified as a Enzyme.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4298054. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Mencari informasi yang ramah bagi pasien?

Stem Bromelain di PillFYI

Data Cepat

Tautan Eksternal

ChEMBL CHEMBL4298054

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.